Connect with us

Technology

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Published

on

Evolution of Ferment conference to kick off Summer 2025

BOSTON, Feb. 6, 2025 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the 2025 Ferment Series, an evolution of its flagship annual conference dedicated to advancing Ginkgo’s mission of making biology easier to engineer. Throughout 2025, Ginkgo product teams will hold a series of focused Ferments at Ginkgo’s beautiful event venue, located at 19 Fid Kennedy Ave in Boston’s historic Seaport District, just a five-minute walk from Ginkgo’s headquarters.

Each Ferment in the 2025 series will dive deep into specific focus areas—spanning Ginkgo’s cell engineering and biosecurity offerings—and highlight how Ginkgo’s broad horizontal platform for engineering biology is enabling transformative solutions across markets including pharma & biotech, agriculture, industrial biotech, government, and beyond. Speawkers and panelists will include Ginkgo experts, partners, and industry leaders who are applying engineered biology to discover, optimize, and manufacture cutting-edge products.

Attendees will also get a close look at Ginkgo’s technologies and the innovations they have delivered to partners around the world. In addition, entirely new products and next-generation services will be showcased, including Ginkgo Datapoints’ high-throughput AI-driven data generation services; Ginkgo Automation’s Reconfigurable Automation Cart (RAC) systems; and Ginkgo Biosecurity’s product suite anchored by Canopy (persistent, environmental pathogen monitoring) and Horizon (data-driven global threat intelligence).

“We made big changes in 2024, and our mission is stronger than ever,” said Jason Kelly, co-founder and CEO of Ginkgo Bioworks. “Whether you’re seeking the perfect antibody, looking to spin up a data generation engine to train your biological AI model, outfitting your lab with extensible and flexible automation, or building a new biosecurity solution to meet your mission’s demands, you can find your needle in our tech stack. We’re excited to show how the platform is evolving, and our new automation capabilities, expanded AI offerings, and next-gen data services will all be on full display at our 2025 Ferment event series. Join us as we celebrate the transformative power of biology and the foundational advancements being made by pioneers across our industry.”

A larger, platform-wide Ferment will return in 2026, alternating years with targeted business-specific gatherings.

2025 Ferment Series Calendar

Summer: Datapoints x AI
Ginkgo Datapoints generates high-quality data at the scale, price, and speed you need. Learn more about our new data-generation services (Functional Genomics & Antibody Developability) and dive into the AI models that we’re deploying and leveraging to accelerate biotech R&D.September: Ginkgo Biopharma Solutions
Ginkgo Biopharma Solutions partners to accelerate your preclinical drug discovery and development research with cutting-edge automation, AI-driven tools, and world-class scientific expertise. Our solutions and products streamline research, enhance efficiency, and empower drug developers to push the boundaries of innovation. Join us to explore our latest offerings and see how our teams help bring therapeutics from concept to clinic.October: Biosecurity
Exploring the future of biosecurity. Experts from government and industry will discuss strategies for identifying, monitoring, and mitigating biological risks.November: Automation
Demonstrations of Ginkgo’s RAC Automation systems, plus in-depth tours of the Foundry to illustrate how large-scale data generation and new automation tech are fueling breakthroughs in cell programming.

Dates are subject to change.

Ginkgo’s Agriculture team is especially excited to meet with partners, old and new, at World AgriTech in San Francisco (March) and ABIM (October), in addition to other industry conferences. As a Gold Sponsor of World AgriTech SF, Ginkgo will be hosting a tour of its R&D facility in West Sacramento, CA on March 10, 2025. Find out more about that pre-summit tour here.

Connect with fellow innovators and leaders, and develop the relationships and ideas that will shape the future of biotechnology. For more information about Ginkgo’s 2025 Ferment series and to subscribe to updates, please visit our series home page, 

About Ginkgo Bioworks:
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.

GINKGO BIOWORKS INVESTOR CONTACT:
investors@ginkgobioworks.com

GINKGO BIOWORKS MEDIA CONTACT:
press@ginkgobioworks.com

Forward-Looking Statements of Ginkgo Bioworks
This press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the capabilities and potential success of Ginkgo’s cell engineering and biosecurity offerings. These forward-looking statements generally are identified by the words “believe,” “can,” “project,” “potential,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) volatility in the price of Ginkgo’s securities due to a variety of factors, including changes in the competitive and highly regulated industries in which Ginkgo operates and plans to operate, variations in performance across competitors, and changes in laws and regulations affecting Ginkgo’s business, (ii) the ability to implement business plans, forecasts, and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations, (vi) the outcome of any pending or potential legal proceedings against Ginkgo, (vii) our ability to realize the expected benefits from and the success of our Foundry platform programs, (viii) our ability to successfully develop engineered cells, bioprocesses, data packages or other deliverables, and (ix) the product development or commercialization success of our customers. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of Ginkgo’s annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 29, 2024, Ginkgo’s most recent quarterly report on Form 10-Q, and other documents filed by Ginkgo from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Ginkgo assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Ginkgo does not give any assurance that it will achieve its expectations.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-host-6th-annual-ferment-as-boston-based-conference-series-302370156.html

SOURCE Ginkgo Bioworks

Continue Reading

Technology

LAZARD GLOBAL TOTAL RETURN AND INCOME FUND DECLARES MONTHLY DISTRIBUTION AND ISSUES ESTIMATED SOURCES OF THE DISTRIBUTION ANNOUNCED IN SEPTEMBER

Published

on

By

NEW YORK, Oct. 22, 2026 /PRNewswire/ — Lazard Global Total Return and Income Fund, Inc. (the “Fund”) (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.15340 per share on the Fund’s outstanding common stock. The distribution is payable on November 24, 2026, to shareholders of record on November 10, 2026. The ex-dividend date is November 10, 2026.

The Fund will pay a previously declared distribution today, October 22, 2026. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today’s distribution, from the following sources: net investment income, net realized capital gains (short-term and long-term), and return of capital. All amounts are expressed per share of common stock and are based on accounting principles generally accepted in the US, which may differ from federal income tax regulations.

Current Distribution

% of the Current Distribution

Total Cumulative Distributions for the Fiscal Year to Date

% of the Total Cumulative Distributions for the Fiscal Year to Date

Net Income

$0.02003

13 %

$0.20541

13 %

Net Realized Short-Term Capital Gains

$0.00000

0 %

$0.00000

0 %

Net Realized Long-Term Capital Gains

$0.13337

87 %

$0.80950

53 %

Return of Capital

$0.00000

0 %

$0.51909

34 %

Total

$0.15340

100 %

$1.53400

100 %

Average annual total return (in relation to NAV) for the 5-year period ending on September 30, 2026

6.36 %

Annualized current distribution rate expressed as a percentage of NAV as of September 30, 2026

10.22 %

Cumulative total return (in relation to NAV) for the fiscal year through September 30, 2026

5.81 %

Cumulative fiscal year distributions as a percentage of NAV as of September 30, 2026

7.66 %

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s Managed Distribution Policy.

The Fund estimates that it has distributed more than its net investment income and net realized capital gains; therefore, a portion of your distribution may be return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income”.

The amounts and sources of distributions reported above are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund provides financial intermediary firms the information necessary to produce the Form 1099-DIV, and then the relevant financial intermediary firm will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes. If you have any questions, or need additional information, please call us at 1-800-823-6300.

Portfolio data as of September 30, 2026, including performance, asset allocation, top 10 holdings, sector weightings, regional exposure, and other Fund characteristics have been posted on Lazard Asset Management’s (“LAM”) website, www.LazardAssetManagement.com.

The Fund’s investment objective is total return, consisting of capital appreciation and current income. The Fund’s net assets are invested in a portfolio of approximately 60 to 80 US and non-US equity securities, including American Depository Receipts, generally of companies with market capitalizations greater than $2 billion, and may include investments in emerging markets. The Fund also invests in emerging market currencies (primarily by entry into forward currency contracts), or instruments whose value is derived from the performance of an underlying emerging market currency, and also may invest in debt obligations, including government, government agency and corporate obligations and structured notes denominated in emerging market currencies.

An indirect subsidiary of Lazard, Inc. (NYSE: LAZ), LAM, the Fund’s investment manager, offers a range of equity, fixed-income, and alternative investment products worldwide. As of September 30, 2026, LAM and affiliated asset management companies in the Lazard Group managed $284.0 billion worth of client assets. For more information about LAM, please go to www.LazardAssetManagement.com.

Media contact:

Investor contact:

Aziz Nayani, +1 212 632 6042

Ben Wulfsohn, +1 800 823 6300

aziz.nayani@lazard.com

ben.wulfsohn@lazard.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lazard-global-total-return-and-income-fund-declares-monthly-distribution-and-issues-estimated-sources-of-the-distribution-announced-in-september-302917400.html

SOURCE Lazard Global Total Return and Income Fund, Inc.

Continue Reading

Technology

Norton LifeLock Benefit Solutions Introduces Norton Money Workplace

Published

on

By

New offering combines financial visibility and protection with personalized guidance, planning and earned-wage access for life’s most important financial moments

TEMPE, Ariz., Oct. 22, 2026 /PRNewswire/ — Norton LifeLock Benefit Solutions, the employee benefits division of Gen (NASDAQ: GEN), has announced the launch of Norton Money Workplace, a new financial wellness benefit employers can offer employees to help them better understand, protect and grow their financial lives through one connected experience.

As employees navigate an increasingly complex financial landscape — from managing everyday expenses and debt to planning for retirement, education, and major life events — they’re also facing growing exposure to scams, fraud and identity threats. At the same time, employers are looking for benefits that deliver meaningful everyday value while helping reduce the financial stress that impacts employee wellbeing. Norton Money Workplace is designed to meet both needs by bringing together financial visibility, protection, personalized guidance, and planning into one experience. It helps employees manage debt, plan for education expenses, prepare for retirement, and navigate major financial decisions at every stage of life.

“Most financial wellness benefits solve one problem or serve one moment in an employee’s life. We saw an opportunity to do something different,” said Tim Hong, Global Head of Financial Wellness Technology at Gen. “Employees need support that’s just as relevant when they’re building financial habits as when they’re buying a home, navigating student loans or preparing for retirement. Our goal is to give employers a benefit that grows with their workforce and helps employees feel more confident navigating whatever life brings. That’s the future we’re building toward.”

Norton Money Workplace delivers that support for employees through four core capabilities. Together, they help employees understand where they stand financially, identify the steps they can take next, and build greater financial confidence over time:

Financial Visibility: Securely connect accounts to understand spending, cash flow, net worth, and credit in one place so employees have a clearer picture of their overall financial position.Financial Protection: Helps catch potential issues earlier and guides employees to take action before they become a larger issue.Guidance & Education: Employees receive personalized financial insights and expert-created education so they can better understand their options and determine appropriate next steps.Planning & Action – Employees can build personalized financial and retirement plans, navigate education costs and student debt, connect with Certified Financial Professional coaching, and receive actionable direction for important financial decisions.

Gen has spent decades helping people stay safer in an increasingly connected world through Cyber Safety, online privacy and identity protection. Today, its solutions also support people’s financial lives, from understanding spending and credit to planning for major decisions. Norton Money Workplace builds on that foundation, bringing Cyber Safety, identity protection and financial wellness together in a single benefit. Rather than employers and their payroll partners stitching together separate point solutions, they get one connected experience, and employees get support that protects their finances, identity and safety online, all in one place. 

“Employees are managing more of their financial lives online than ever before, and they need benefits that reflect that reality,” said Casey Cullinan, Head of Norton LifeLock Benefit Solutions at Gen. “By bringing together trusted cyber protection with proven financial technology, we’re helping employers deliver support that’s more relevant, more useful and built for the way people live today. It’s another example of how we’re delivering more value by connecting Gen’s strengths across our portfolio.”

Norton Money Workplace marks the next chapter in Gen’s journey to protect and empower people’s digital and financial lives. For decades, Norton and LifeLock have helped people stay safer online through Cyber Safety and identity protection — and more recently, through tools that help them understand and manage their money. Norton Money Workplace builds on that foundation, bringing these capabilities together in a single employee benefit, with more to come as Gen’s employee benefits division works toward an even more connected, all-in-one solution for employees’ digital and financial lives. Norton Money Workplace will be available beginning in December 2026. Learn more here.

About Norton LifeLock Benefit Solutions, part of Gen 

Norton LifeLock Benefit Solutions helps employers equip their employees with digital and financial protection through comprehensive benefits that combine award-winning technology with expert restoration support. Norton LifeLock Benefit Solutions is part of Gen (NASDAQ: GEN), a global company dedicated to powering Digital Freedom with a family of trusted consumer brands including Norton, LifeLock and MoneyLion. Gen empowers nearly 500 million users in more than 150 countries through its products and services that span cybersecurity, online privacy, identity protection and financial wellness. Through Norton LifeLock Benefit Solutions, Gen brings that protection into the workplace, partnering with more than 12,000 employers to help employees safeguard their identities, navigate digital risks and take greater control of their financial lives. Learn more at GenDigital.com. 

Media Contact

Audra Proctor
Gen
Press@GenDigital.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/norton-lifelock-benefit-solutions-introduces-norton-money-workplace-302917367.html

SOURCE Gen Digital Inc.

Continue Reading

Technology

Quantinuum to Report Third Quarter Financial Results on November 5, 2026

Published

on

By

BROOMFIELD, Colo., Oct. 22, 2026 /PRNewswire/ — Quantinuum Inc. (NASDAQ: QNT) (“Quantinuum”) today announced it will release its financial results for the third quarter ended September 30, 2026, on November 5, 2026, after market close.

Quantinuum will host a conference call at 5:00 PM Eastern time that same day to discuss its financial results. The call will be available through a live webcast available here.

An archive replay of the webcast will be made available on the Quantinuum Investor Relations website following the call and will remain available for one year.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity as of December 31, 2025. Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar and Singapore.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/quantinuum-to-report-third-quarter-financial-results-on-november-5-2026-302917284.html

Continue Reading

Trending